Evaluating the Effectiveness of Adding Rituximab to Standard Treatment for Thrombotic Thrombocytopenic Purpura (TTP)
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Barbara Konkle, MD
University of Pennsylvania
Principal Investigator - Christopher Hillyer, MD
Emory University
Principal Investigator - Cindy Leissinger, MD
Tulane University
Principal Investigator - Darrell Triulzi, MD
University of Pittsburgh Presbyterian and Shadyside/Children's Hospital Pittsburgh
Principal Investigator - David Kuter, MD
Massachusetts General Hospital
Principal Investigator - Eliot Williams, MD, PhD
University of Wisconsin, Madison
Principal Investigator - Ellis Neufeld, MD
Boston Children's Hospital
Principal Investigator - James Bussel, MD
Weill Medical Colllege, Cornell University
Principal Investigator - James George, MD
University of Oklahoma
Principal Investigator - Jan McFarland, MD
Froedtert Hospital
Principal Investigator - John Hess, MD
University of Maryland
Principal Investigator - Joseph Kiss, MD
University of Pittsburgh
Study Chair - Keith McCrae, MD
University Hospitals Cleveland Medical Center
Principal Investigator - Mark Brecher, MD
University of North Carolina, Chapel Hill
Principal Investigator - Paul Ness, MD
Johns Hopkins University
Principal Investigator - Ronald Strauss, MD
University of Iowa
Principal Investigator - Sherrill Slichter, MD
University of Washington Medical Center/Fred Hutchinson Cancer Research Center (FHCRC)
Principal Investigator - Susan F. Assmann, PhD
New England Research Institutes, Inc.
Principal Investigator - Thomas Ortel, MD
Duke University
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
23 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- University of Alabama, Birmingham
Birmingham, Alabama, United States
- Emory University
Atlanta, Georgia, United States
- University of Iowa
Iowa City, Iowa, United States
- Tulane University Health Sciences Center
New Orleans, Louisiana, United States
- Johns Hopkins Hospital
Baltimore, Maryland, United States
- University of Maryland Medical Center
Baltimore, Maryland, United States
- Beth Israel Deaconess Medical Center
Boston, Massachusetts, United States
- Brigham and Women'S Hospital
Boston, Massachusetts, United States
- Children'S Hospital Boston
Boston, Massachusetts, United States
- Massachusetts General Hospital
Boston, Massachusetts, United States
- New York-Presbyterian Hospital/weill Cornell Medical Center
New York, New York, United States
- University of North Carolina Hospitals
Chapel Hill, North Carolina, United States
- Duke University Medical Center
Durham, North Carolina, United States
- University Hospital Cleveland
Cleveland, Ohio, United States
- Integris Baptist Medical Center
Oklahoma City, Oklahoma, United States
- University of Oklahoma Health Sciences Center
Oklahoma City, Oklahoma, United States
- University of Pennsylvania
Philadelphia, Pennsylvania, United States
- Children'S Hospital of Pittsburgh
Pittsburgh, Pennsylvania, United States
- University of Pittsburgh Presbyterian and Shadyside Hospital
Pittsburgh, Pennsylvania, United States
- Puget Sound Blood Center
Seattle, Washington, United States
- Gunderson Clinic, Ltd
La Crosse, Wisconsin, United States
- University of Wisconsin at Madison
Madison, Wisconsin, United States
- Froedtert Memorial Lutheran Hospital
Milwaukee, Wisconsin, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 30 Apr 2009
- Primary completion
- 28 Feb 2010
- Completion
- 28 Feb 2010
- Last update posted
- 22 Jul 2013
- Registered enrollment
- 3
- Registry id
- NCT00799773
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.